Ilaria Chiarugi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ilaria Chiarugi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Maestrelli
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
4 shared publications - Anna Rita Bilia
Department of Chemistry Ugo Schiff, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
3 shared publications - Sandra Ristori
University of Florence
3 shared publications - Giulia Piomboni
Department of Chemistry “Ugo Schiff” (DICUS), University of Florence, Via Ugo Schiff 6, 50019 Florence, FI, Italy
2 shared publications - Alessio Gnerucci
Department of Physics and Astronomy, University of Florence, Via Sansone, 1, 50019 Sesto Fiorentino, FI, Italy
1 shared publication - Diletta Biagi
Menarini Manufacturing, Logistic and Services s.r.l., Via Rosolino Pilo 4, 50131 Florence, Italy
1 shared publication
Latest Publications
- Open Access
- 29 March 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 697, 126821
Newly customized cationic ẞ-cyclodextrins as potential nanovectors for gene delivery
- 29 March 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 697, 126821
Open AccessNewly customized cationic ẞ-cyclodextrins as potential nanovectors for gene delivery
- Open Access
- 21 February 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 265
Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.
- 21 February 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 265
Open AccessNon-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.
- Open Access
- 24 November 2025
- Published by MDPI AG in Preprints.org
Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.
- 24 November 2025
- Published by MDPI AG in Preprints.org
Open AccessNon-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.
- Open Access
- 24 January 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (2) , 165
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate
Orally disintegrating granules (ODGs) are a pharmaceutical form commonly used for the administration of NSAIDs because of their easy assumption and fast dispersion. The development of ODGs is not easy for drugs like dexketoprofen trometamol (DXKT), which have a bitter and burning taste. In this work, high-shear coating (HSC) was used as an innovative technique for DKXT taste masking. This study focused on coating DXKT granules using the HSC technique with a low-melting lipid excipient, glyceryl distearate (GDS). The HSC technique allowed for the coating to be developed through the thermal rise resulting from the friction generated by the granules movement inside the equipment, causing the coating excipient to soften. The design of the experiment was used to find the best experimental coating conditions in order to gain effective taste masking by suitably reducing the amount of drug released in the oral cavity. The influence of the granule dimensions was also investigated. Coating effectiveness was evaluated using a simulated saliva dissolution test. It was found that low impeller speed (300 rpm) and a 20% coating excipient were effective in suitably reducing the drug dissolution rate and then in taste masking. The coated granules were characterized for their morphology and solid-state properties by SEM, BET, XRPD, DSC, and NIR analyses. A human taste panel test confirmed the masking of DXKT taste in the selected batch granules.
- 24 January 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (2) , 165
Open AccessTaste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate
Orally disintegrating granules (ODGs) are a pharmaceutical form commonly used for the administration of NSAIDs because of their easy assumption and fast dispersion. The development of ODGs is not easy for drugs like dexketoprofen trometamol (DXKT), which have a bitter and burning taste. In this work, high-shear coating (HSC) was used as an innovative technique for DKXT taste masking. This study focused on coating DXKT granules using the HSC technique with a low-melting lipid excipient, glyceryl distearate (GDS). The HSC technique allowed for the coating to be developed through the thermal rise resulting from the friction generated by the granules movement inside the equipment, causing the coating excipient to soften. The design of the experiment was used to find the best experimental coating conditions in order to gain effective taste masking by suitably reducing the amount of drug released in the oral cavity. The influence of the granule dimensions was also investigated. Coating effectiveness was evaluated using a simulated saliva dissolution test. It was found that low impeller speed (300 rpm) and a 20% coating excipient were effective in suitably reducing the drug dissolution rate and then in taste masking. The coated granules were characterized for their morphology and solid-state properties by SEM, BET, XRPD, DSC, and NIR analyses. A human taste panel test confirmed the masking of DXKT taste in the selected batch granules.